China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Assets

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Cash & Equivalents	28.18	21.17	18.1	18.51	12.07	11.47	17.37	2.98	15.52	0.03
Short-Term Investments	0.14	0.14	0.14	-	-	-	-	-	-	-
Cash & Short-Term Investments	28.32	21.31	18.24	18.51	12.07	11.47	17.37	2.98	15.52	0.03
Cash Growth (YoY)	55.30%	15.09%	51.09%	61.47%	-30.50%	284.60%	11.88%	9417.68%	16.43%	-99.70%
Accounts Receivable	0.93	1.34	1.3	1.66	1.31	1.31	1.34	3.32	3.37	3.88
Other Receivables	2.2	1.43	0.47	-0.05	0.03	-0.03	0.23	3.29	0.66	3.64
Receivables	3.23	2.87	1.9	1.61	1.35	1.28	1.58	8.11	5.53	9.02
Inventory	2.96	1.84	1.13	1.59	0.81	0.58	0.58	0.69	1.07	1.37
Restricted Cash	0	0.03	0.03	-	0.01	-	-	-	0.05	-
Other Current Assets	-	-	-	0.28	-	0.16	-	0.58	0.29	1.23
Total Current Assets	34.51	26.04	21.3	21.99	14.23	13.5	19.52	12.36	22.45	11.66
Property, Plant & Equipment	0.24	0.3	0.36	0.44	0.56	1.07	1.27	1.36	1.59	1.65
Other Intangible Assets	0.01	0.01	0.01	0.02	0.02	0.02	0.03	0.03	0.04	0.04
Other Long-Term Assets	-	-	-	8.55	8.31	-	8.74	8.43	9.46	9.31
Total Assets	34.75	26.35	21.66	31	23.13	14.59	29.55	22.18	33.55	22.67

Liabilities

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Accounts Payable	0.5	0.53	1.16	1.66	1.28	1.32	1.38	1.56	1.48	1.49
Accrued Expenses	1.93	2.08	1.78	1.72	1.59	2.08	1.74	1.57	2.01	1.4
Short-Term Debt	0.36	0.98	0.7	9.53	3.32	3.18	8.53	1.21	10.73	2.12
Current Portion of Long-Term Debt	-	0	0.01	0.01	0.02	0.02	0.01	-	0.01	0.02
Current Portion of Leases	0.07	0.06	0.06	0.03	0.06	0.06	0.06	0.37	-	0.49
Current Income Taxes Payable	0	1.04	1.03	1.09	1.05	1.04	1.1	1.07	1.17	1.18
Current Unearned Revenue	0.1	0.07	0.06	0.19	0.19	-	0.17	-	-	-
Other Current Liabilities	1.39	1.2	1.21	1.42	1.39	1.51	1.52	1.51	1.72	2.17
Total Current Liabilities	4.35	5.96	6.01	15.66	8.9	9.2	14.5	7.29	17.12	8.88
Long-Term Debt	0.64	0.07	0.1	0.12	0.12	0.11	0.12	-	-	-
Long-Term Leases	0.05	0.09	0.12	0.18	0.18	0.2	0.25	-	-	-
Other Long-Term Liabilities	-	-0	-	-	-	-	-	-	-	-
Total Liabilities	5.05	6.12	6.22	15.96	9.2	9.51	14.86	7.29	17.12	8.88

Shareholders' Equity

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Common Stock	64.13	55.38	44.53	7.73	39.67	1.45	0.91	0.29	0.16	0.07
Additional Paid-In Capital	-	-	-	33.39	-	35.95	35.59	32.56	30.99	26.01
Retained Earnings	-34.22	-34.38	-28.02	-25.51	-24.71	-31.31	-21.61	-17.18	-15.69	-13.04
Comprehensive Income & Other	-0.2	-0.77	-1.08	-0.57	-1.03	-1.02	-0.2	-0.78	0.96	0.76
Shareholders' Equity	29.71	20.23	15.44	15.03	13.93	5.08	14.69	14.89	16.42	13.79
Total Liabilities & Equity	34.75	26.35	21.66	31	23.13	14.59	29.55	22.18	33.55	22.67

Additional Metrics

Fiscal Quarter	H2 2026	H1 2026	H2 2025	H1 2025	H2 2024	H1 2024	H2 2023	H1 2023	H2 2022	H1 2022
Period Ending	Mar 31, 2026	Sep 30, 2025	Mar 31, 2025	Sep 30, 2024	Mar 31, 2024	Sep 30, 2023	Mar 31, 2023	Sep 30, 2022	Mar 31, 2022	Sep 30, 2021
Total Debt	1.12	1.2	0.98	9.87	3.7	3.57	8.96	1.58	10.74	2.63
Net Cash (Debt)	27.2	20.1	17.25	8.64	8.38	7.89	8.41	1.41	4.78	-2.6
Net Cash Growth (YoY)	57.65%	132.67%	106.00%	9.47%	-0.39%	461.53%	75.82%	-	319.07%	-
Net Cash Per Share	-	-	-	-	-	-	-	-	2.35	-0.15
Filing Date Shares Outstanding	0.4	0.01	0.01	0	0	0	0	0	0	-
Total Common Shares Outstanding	0.01	0.01	0	0	0	0	0	0	0	-
Working Capital	30.16	20.08	15.28	6.32	5.33	4.3	5.02	5.07	5.33	2.78
Book Value Per Share	2480.58	2092.62	13461.00	366706.24	605671.57	634541.88	2938259.00	7444807.50	16424708.00	-
Tangible Book Value	29.7	20.23	15.43	15.02	13.91	5.05	14.66	14.86	16.39	13.75
Tangible Book Value Per Share	2480.05	2091.74	13450.70	366318.49	604841.09	631727.63	2932685.40	7429445.50	16385946.00	-
Machinery	1.1	1.06	1.04	1.12	1.19	1.16	1.24	1.15	1.27	1.21
Construction In Progress	-	-	-	-	-	-	-	0.34	0.36	0.36
Leasehold Improvements	1.64	1.59	1.56	1.61	1.56	1.55	1.64	1.58	1.78	1.75

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 1, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 17, 2026

Data Sources Report a data error